ÉTUDE PRODIGE 102-FFCD-Safe ESO - En cours de lancement
Title
Randomized phase II study: anti-PD-1 (or PD-L1) alone versus FOLFOX chemotherapy and anti PD-1 (or PD-L1) for elderly or non-fit patients with squamous cell oesophageal cancer in first line setting
Coordonateur
JARY M.
Co-Coordonateur
TURPIN A.
Promoteur
FFCD